0001145549-21-016288.txt : 20210316 0001145549-21-016288.hdr.sgml : 20210316 20210316114052 ACCESSION NUMBER: 0001145549-21-016288 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 EFFECTIVENESS DATE: 20210316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Manager Directed Portfolios CENTRAL INDEX KEY: 0001359057 IRS NUMBER: 571138125 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-21897 FILM NUMBER: 21744416 BUSINESS ADDRESS: STREET 1: C/O U.S. BANCORP FUND SERVICES, LLC STREET 2: 615 E. MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 9522306140 MAIL ADDRESS: STREET 1: C/O U.S. BANCORP FUND SERVICES, LLC STREET 2: 615 E. MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 FORMER COMPANY: FORMER CONFORMED NAME: Roxbury Funds DATE OF NAME CHANGE: 20060411 0001359057 S000060175 Spyglass Growth Fund C000196940 Institutional Shares SPYGX C000196941 Retail Shares 0001359057 S000063161 Argent Small Cap Fund C000204775 Institutional Shares ACMSX C000204776 Retail Shares 0001359057 S000063189 iM Dolan McEniry Corporate Bond Fund C000204812 Advisor Shares IDMAX C000204813 Institutional Shares IDMIX 0001359057 S000064047 iM DBi Managed Futures Strategy ETF C000207161 iM DBi Managed Futures Strategy ETF DBMF 0001359057 S000066474 iM DBi Hedge Strategy ETF C000214391 iM DBi Hedge Strategy ETF DBEH N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0001359057 XXXXXXXX false false false N-1A S000063161 true S000066474 true S000064047 true S000063189 true S000060175 true Manager Directed Portfolios 811-21897 0001359057 549300J0JL5T81OQ6O93 615 E. Michigan Street Milwaukee 53202 US-WI US 4142873101 U.S. Bank N.A. 1555 North River Center Drive Suite 302 Milwaukee 53212 8336121912 Custody Records U.S. Bancorp Fund Services LLC 615 East Michigan Street 3rd Floor Milwaukee 53202 8336121912 Fund Adminstration Transfer Agent and Fund Accounting Records Quasar Distributors LLC 777 East Wisconsin Avenue 6th Floor Milwaukee 53202 8336121912 Distributor and Underwriter Records N N N N-1A 9 Y Scott Craven Jones N/A N Gaylord Brickwood Lyman Jr. N/A N Lawrence T. Greenberg N/A N James Robert Schoenike 001041981 Y Justin Dausch N/A 223 Wilmington West Chester Pike Suite 216 Chadds Ford 19317 XXXXXX N N N N N N Quasar Distributors LLC 8-52323 000103848 N/A N N BBD LLP 00552 N/A N N N N N N Argent Small Cap Fund S000063161 549300R68Q3CKSOCOT61 N 2 0 0 N/A N N N N N/A N/A N/A N/A N N N N Argent Capital Management LLC 801-55903 000107930 N/A N U.S. Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4O33MV32P92 N U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N Merrill Lynch, Inc. 8-33359 000016139 549300PMHS66E71I2D34 58767.000000000000 Jones Trading Institutional Services LLC 8-26089 000006888 2138008JJ5PA8H5UIL69 50984.000000000000 Instinet LLC 8-23669 000007897 549300MGMN3RKMU8FT57 29174.000000000000 Craig-Hallum Capital Group LLC 8-65407 000121395 549300YWNPUXBR9XZW77 6422.000000000000 JMP Securities LLC 8-39613 000022208 549300IDHEFHQ741DW68 5674.000000000000 Stifel Nicolaus and Company Incorporated 8-1447 000000793 5WUVMA08EYG4KEUPW589 3025.000000000000 Needham and Company LLC 8-33772 000016360 254900J2GFQ4J4NK1J89 2530.000000000000 BNY Mellon Capital Markets, LLC 8-35255 000017454 VJW2DOOHGDT6PO0ZRO63 1851.000000000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 1453.000000000000 163957.000000000000 U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 108337283.000000000000 JMP Securities LLC 8-39613 000022208 549300IDHEFHQ741DW68 137838.000000000000 108475121.000000000000 N iM DBi Hedge Strategy ETF S000066474 549300QE4D9YHXO3LL14 N 1 0 0 N/A N N N N N/A N/A N/A N/A N N N N iM Global Partner US LLC 801-113506 000297426 969500O9DNGVY5KDT708 N Dynamic Beta investments LLC 801-77106 000164972 254900F78BE56PYS4F84 Y N U.S. Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4O33MV32P92 N U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Futures commission merchants and commodity clearing organizations - rule 17f-6 (17 CFR 270.17f-6) N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 3455.570000000000 U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 3456.000000000000 Mizuho Securities LLC 8-37710 000119647 7TK5RJIZDFROZCA6XF66 5166.000000000000 8622.000000000000 U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 43461999.000000000000 43461999.000000000000 N iM DBi Managed Futures Strategy ETF S000064047 549300IOBUR45NI3X582 N 1 0 0 N/A N N N N N/A N/A N/A N/A N N N N iM Global Partner US LLC 801-113506 000297426 969500O9DNGVY5KDT708 N Dynamic Beta investments LLC 801-77106 000164972 254900F78BE56PYS4F84 Y N U.S. Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4O33MV32P92 N U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Futures commission merchants and commodity clearing organizations - rule 17f-6 (17 CFR 270.17f-6) N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 2311.020000000000 Societe Generale Securities Corp. 8-22522 000007616 969500BBKWJRVJB87687 43433.000000000000 U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 2311.000000000000 4574.000000000000 U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 76378428.000000000000 76378428.000000000000 N iM Dolan McEniry Corporate Bond Fund S000063189 549300UJ0H10QPU5V491 N 2 0 0 N/A N N N N N/A N/A N/A N/A N N N N iM Global Partner US LLC 801-113506 000297426 969500O9DNGVY5KDT708 N Dolan McEniry Capital Management LLC 801-54756 000108658 254900920DFC3A2UF074 Y N U.S. Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4O33MV32P92 N U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N 0.000000000000 MarketAxess Corp. 8-50727 000044542 GPSMMRI21JE7ZCVYF972 15528367.000000000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 8990620.000000000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 4781372.000000000000 Morgan Stanley & Co., Inc. 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 4377871.000000000000 Jefferies & Company, Inc. 8-15074 000002347 58PU97L1C0WSRCWADL48 3384400.000000000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 3370511.000000000000 Barclay Investments LLC 8-16935 000006159 254900YRC13GGERHVR90 3238845.000000000000 Sumridge Partners LLC 8-68454 000152437 529900ECMK8VI6Q1FG89 2770391.000000000000 Wells Fargo Securities LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 2473003.000000000000 BOFA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 2281279.000000000000 61108616.000000000000 N Spyglass Growth Fund S000060175 549300VSBO6U4TKNS090 N 2 0 0 N/A N N N N N/A N/A N/A N/A N N N N Spyglass Capital Management LLC 801-112070 000281266 254900IFBWVZ8D9XH541 N U.S. Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4O33MV32P92 N U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N Williams Trading LLC 8-50372 000043678 254900XH331390J1WT63 897542.000000000000 897542.000000000000 0.000000000000 N true INTERNAL CONTROL RPT 2 argent123120n-cen.htm AUDIT INTERNAL CONTROL REPORTS

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

To the Board of Trustees of Manager Directed Portfolios 

and the Shareholders of Argent Small Cap Fund 

  

  

In planning and performing our audit of the financial statements of Argent Small Cap Fund, a series of shares of beneficial interest in Manager Directed Portfolios (the “Fund”), as of December 31, 2020, and for the year then ended, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting.  Accordingly, we express no such opinion. 

  

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America (“GAAP”).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.  

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness, as defined above, as of December 31, 2020.  

  

This report is intended solely for the information and use of management and the shareholders of Argent Small Cap Fund, the Board of Trustees of Manager Directed Portfolios and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ BBD, LLP 

  

BBD, LLP 

  

  

Philadelphia, Pennsylvania 

February 25, 2021 

  

INTERNAL CONTROL RPT 3 imdbi123120n-cen.htm AUDIT INTERNAL CONTROL REPORTS

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

To the Board of Trustees of Manager Directed Portfolios 

and the Shareholders of iM DBi Managed Futures Strategy ETF 

and iM DBi Hedge Strategy ETF   

  

In planning and performing our audits of the financial statements of iM DBi Managed Futures Strategy ETF and iM DBi Hedge Strategy ETF, each a series of shares of beneficial interest in Manager Directed Portfolios (the “Funds”), as of December 31, 2020, and for the year then ended, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Funds’ internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds' internal control over financial reporting.  Accordingly, we express no such opinion. 

  

The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America (“GAAP”).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.  

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds' annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Funds' internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Funds’ internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness, as defined above, as of December 31, 2020.  

  

This report is intended solely for the information and use of management and the shareholders of iM DBi Managed Futures Strategy ETF and iM DBi Hedge Strategy ETF, the Board of Trustees of Manager Directed Portfolios and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ BBD, LLP 

  

BBD, LLP 

  

  

Philadelphia, Pennsylvania 

February 25, 2021 

  

INTERNAL CONTROL RPT 4 imdolan123120n-cen.htm AUDIT INTERNAL CONTROL REPORTS

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

To the Board of Trustees of Manager Directed Portfolios 

and the Shareholders of iM Dolan McEniry Corporate Bond Fund 

  

  

In planning and performing our audit of the financial statements of iM Dolan McEniry Corporate Bond Fund, a series of shares of beneficial interest in Manager Directed Portfolios (the “Fund”), as of December 31, 2020, and for the year then ended, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting.  Accordingly, we express no such opinion. 

  

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America (“GAAP”).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.  

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness, as defined above, as of December 31, 2020.  

  

This report is intended solely for the information and use of management and the shareholders of iM Dolan McEniry Corporate Bond Fund, the Board of Trustees of Manager Directed Portfolios and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ BBD, LLP 

  

BBD, LLP 

  

  

Philadelphia, Pennsylvania 

February 25, 2021 

  

INTERNAL CONTROL RPT 5 spyglass123120n-cen.htm AUDIT INTERNAL CONTROL REPORTS

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

To the Board of Trustees of Manager Directed Portfolios 

and the Shareholders of Spyglass Growth Fund 

  

  

In planning and performing our audit of the financial statements of Spyglass Growth Fund, a series of shares of beneficial interest in Manager Directed Portfolios (the “Fund”), as of December 31, 2020, and for the year then ended, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting.  Accordingly, we express no such opinion. 

  

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America (“GAAP”).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.  

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness, as defined above, as of December 31, 2020.  

  

This report is intended solely for the information and use of management and the shareholders of Spyglass Growth Fund, the Board of Trustees of Manager Directed Portfolios and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ BBD, LLP 

  

BBD, LLP 

  

  

Philadelphia, Pennsylvania 

February 25, 2021